Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

An antimicrobial peptide of the cathelicidin family that provides innate immune defense by killing pathogens and modulating inflammation and wound healing.

Quick Stats
Studies 2230
Trials 95
Formula C205H340N60O53
Clear All
Utility 1
pubmed Aug 19, 2014

Targeting pro-resolution pathways to combat chronic inflammation in COPD.

Bozinovski. Steven S; Anthony. Desiree D; Vlahos. Ross R

The paper explains why inflammation stays high in COPD lungs and points out that a natural peptide called LL‑37 can bind to a receptor (ALX/FPR2) that usually helps turn inflammation off. In COPD, this “off‑switch” doesn’t work well, and the authors suggest that designing more stable drug‑like versions of the natural anti‑inflammatory signals could help.

Utility 1
pubmed Dec 25, 2013

Positive correlations between hCAP18/LL-37 and chondroitin sulphate levels in chronic periodontitis.

Makeudom. Anupong A; Kulpawaropas. Samakorn S; Montreekachon. Pattanin P; Khongkhunthian. Sakornrat...

The study measured the antimicrobial peptide LL‑37 in gum fluid and found it was higher in people with chronic gum disease. In chronic periodontitis, LL‑37 levels were linked to chondroitin sulphate levels, a pattern not seen in aggressive gum disease. This correlation could help dentists tell the two types of gum disease apart.

Utility 1
pubmed Feb 1, 2014

Peptidoglycan from Staphylococcus aureus has an anti-apoptotic effect in HaCaT keratinocytes mediated by the production of the cellular inhibitor of apoptosis protein-2.

Vázquez-Sánchez. Ernesto Antonio EA; Rodríguez-Romero. Magdalena M; Sánchez-Torr...

A component from Staphylococcus bacteria (peptidoglycan) makes skin cells produce more of the antimicrobial peptide LL‑37 and a protein called cIAP‑2, which together protect the cells from dying when exposed to an inflammatory signal. This anti‑death effect could help skin cells multiply, which may be relevant to conditions like psoriasis, but it doesn’t translate into a clear health‑boosting protocol for the general biohacker audience.

Utility 1
pubmed Jun 1, 2014

Tuberculin skin test and interferon-gamma release assay values are associated with antimicrobial peptides expression in  polymorphonuclear cells during latent tuberculous infection.

Castañeda-Delgado. Julio E JE; Cervantes-Villagrana. Alberto A; Serrano-Escobedo. Carmen J CJ;...

The study found that in people who have been exposed to TB but aren’t sick, higher skin‑test or blood‑test results go along with more of the natural antimicrobial proteins LL‑37 and HNP‑1 in their white blood cells. This suggests those proteins might signal who’s more likely to develop active TB, but it doesn’t give a new treatment or supplement plan.

Utility 1
pubmed Mar 18, 2014

Human corneal epithelial cells produce antimicrobial peptides LL-37 and β-defensins in response to heat-killed Candida albicans.

Hua. Xia X; Yuan. Xiaoyong X; Tang. Xin X; Li. Zhijie Z; Pflugfelder. Stephen C SC; Li. De-Quan DQ

Human eye surface cells naturally make antimicrobial proteins called LL-37 and beta‑defensins. When these cells are exposed to dead Candida fungus, they boost the production of these proteins within a few hours, showing a built‑in defense mechanism for the eye.

Utility 1
pubmed Feb 24, 2014

Activity of host antimicrobials against multidrug-resistant Acinetobacter baumannii acquiring colistin resistance through loss of lipopolysaccharide.

García-Quintanilla. Meritxell M; Pulido. Marina R MR; Moreno-Martínez. Patricia P; Mart&#x...

The study shows that the human antimicrobial peptide LL‑37 can still kill a tough bacteria (Acinetobacter baumannii) even when the bug becomes resistant to the antibiotic colistin by losing its outer coating, and that another natural protein, lysozyme, works even better against those resistant bugs.

Utility 1
pubmed Mar 19, 2014

Human cathelicidin LL-37 resistance and increased daptomycin MIC in methicillin-resistant Staphylococcus aureus strain USA600 (ST45) are associated with increased mortality in a hospital setting.

Sakoulas. George G; Guram. Kripa K; Reyes. Katherine K; Nizet. Victor V; Zervos. Marcus M

The study found that a specific MRSA strain (USA600) is better at surviving attacks from the human immune peptide LL-37 and also shows higher resistance to the antibiotic daptomycin, which together are linked to higher death rates in hospitals.

Utility 1
pubmed Feb 12, 2013

Tumor-produced versican V1 enhances hCAP18/LL-37 expression in macrophages through activation of TLR2 and vitamin D3 signaling to promote ovarian cancer progression in vitro.

Li. Dong D; Wang. Xuan X; Wu. Jun-Lu JL; Quan. Wen-Qiang WQ; Ma. Li L; Yang. Fan F; Wu. Kai-Yin KY;...

The study shows that a protein released by ovarian cancer cells (versican V1) makes immune cells produce more of the antimicrobial peptide LL‑37, and this extra LL‑37 helps the cancer cells grow and spread, using the TLR2/TLR6 receptors and vitamin D signaling pathways.

Utility 1
pubmed Jan 16, 2013

Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV infection of Langerhans cells.

Ogawa. Youichi Y; Kawamura. Tatsuyoshi T; Matsuzawa. Takamitsu T; Aoki. Rui R; Gee. Peter P; Yamashi...

The study shows that when skin cells are infected with HSV‑2 (the virus that causes genital herpes), they release a protein called LL‑37. This protein makes certain immune cells in the skin (Langerhans cells) more likely to get infected by HIV by increasing the number of HIV entry receptors on them. So, LL‑37, which is usually thought of as an antimicrobial defender, can actually help HIV spread if you have a herpes infection.

Utility 1
pubmed Jun 13, 2013

Role of uropathogenic Escherichia coli OmpT in the resistance against human cathelicidin LL-37.

Brannon. John R JR; Thomassin. Jenny-Lee JL; Desloges. Isabelle I; Gruenheid. Samantha S; Le Moual....

The study found that a protein called OmpT in urinary‑tract bacteria can cut up the human antimicrobial peptide LL‑37, but the bacteria usually make only a little OmpT, so this doesn’t make them much more resistant to LL‑37 on its own.

Utility 1
pubmed May 8, 2013

Oxygen deprivation affects the antimicrobial action of LL-37 as determined by microplate real-time kinetic measurements under anaerobic conditions.

Eini. Amir A; Sol. Asaf A; Coppenhagen-Glazer. Shunit S; Skvirsky. Yaniv Y; Zini. Avi A; Bachrach. G...

The study shows that the human antimicrobial peptide LL‑37 works differently depending on oxygen levels: it kills E. coli better when there’s little oxygen, but is less effective against Strep pyogenes under the same low‑oxygen conditions. The researchers created a way to test these effects in lab plates without oxygen.

Utility 1
pubmed Nov 14, 2013

Structural location determines functional roles of the basic amino acids of KR-12, the smallest antimicrobial peptide from human cathelicidin LL-37.

Mishra. Biswajit B; Epand. Raquel F RF; Epand. Richard M RM; Wang. Guangshun G

Researchers studied a tiny piece of the human immune peptide LL-37 called KR-12 and found that swapping out certain positively‑charged building blocks can make it kill bacteria better, but only when the overall molecule is more water‑repelling (hydrophobic). The effect depends on where the swapped parts sit in the peptide’s shape.

Utility 1
pubmed May 29, 2014

Cathelicidin LL-37 and HSV-1 Corneal Infection: Peptide Versus Gene Therapy.

Lee. Chyan-Jang CJ; Buznyk. Oleksiy O; Kuffova. Lucia L; Rajendran. Vijayalakshmi V; Forrester. John...

Scientists tested a special eye‑drop‑like gel that slowly releases the natural peptide LL‑37 to stop herpes eye infections. The gel helped keep corneal implants in place longer and could block the virus from sticking to cells, but it couldn't fully clear an existing infection. Cells engineered to make LL‑37 also reduced virus spread, but neither method alone stopped the virus completely.

Utility 1
pubmed Feb 28, 2013

Toll-like receptor expression and activation in mice with experimental dry eye.

Redfern. Rachel L RL; Patel. Nimesh N; Hanlon. Samuel S; Farley. William W; Gondo. Margaret M; Pflug...

In mice with dry eye, the eye’s immune sensors (TLRs) become more active while the natural antimicrobial peptide LL‑37 (called CRAMP in mice) drops. Adding TLR‑activating substances to the eye makes the cornea swell, lose cells, and get thinner, especially if the surface is already scratched. Similar changes in TLRs and LL‑37 were seen in people with dry‑eye symptoms.

Utility 1
pubmed Apr 17, 2013

Pseudomonas aeruginosa small protease (PASP), a keratitis virulence factor.

Tang. Aihua A; Caballero. Armando R AR; Marquart. Mary E ME; O'Callaghan. Richard J RJ

A study showed that a protein called PASP, secreted by the bacteria Pseudomonas aeruginosa, makes eye infections worse by breaking down important host proteins like the immune peptide LL‑37, but removing PASP makes the infection less severe.

Utility 1
pubmed Feb 4, 2013

Defensin production by human limbo-corneal fibroblasts infected with mycobacteria.

Castañeda-Sánchez. Jorge I JI; García-Pérez. Blanca E BE; Muñoz-Duarte. Ana...

The study shows that eye‑area fibroblast cells naturally make the antimicrobial peptide LL‑37 and other defensins, and that different types of mycobacteria (the bacteria that cause TB and related infections) change how much of these peptides and inflammation signals the cells produce. Some bacteria trigger more LL‑37 but aren’t cleared, while others trigger less peptide but are eliminated.

Utility 1
pubmed Mar 24, 2014

DrsG from Streptococcus dysgalactiae subsp. equisimilis inhibits the antimicrobial peptide LL-37.

Smyth. Danielle D; Cameron. Ainslie A; Davies. Mark R MR; McNeilly. Celia C; Hafner. Louise L; Sripr...

Scientists discovered that a protein made by a type of strep bacteria (called DrsG) can block the activity of the human antimicrobial peptide LL‑37. This blocking ability is similar to other bacterial proteins, but DrsG does not affect the complement system. The finding shows how some bacteria can protect themselves from our natural defenses.